ScholarIQanswers from OpenAlex

Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer

PaperCitations, authors & open-access status

Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer have?

ScholarIQcitation count

Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer has 27 citations in the OpenAlex counts ScholarIQ stores.

When was Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer published?

ScholarIQyear

Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer has 2023 year in the ScholarIQ index.

What is the open-access status of Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer?

ScholarIQoa status

Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer has gold oa status in the ScholarIQ index.

What is the DOI of Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer?

ScholarIQdoi

The DOI for Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer is on the source record.

What is the PMID of Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer?

ScholarIQpmid

The PMID for Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer is on the source record.

What is the OpenAlex record for Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer?

ScholarIQopenalex

The OpenAlex for Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial